News

September 2015

Viewing posts from September , 2015

Nextremity Solutions, Inc. Announces the Issuance of Seven Patents for Use in Foot and Ankle

Warsaw, Indiana — The U.S. Patent and Trademark Office (USPTO) recently awarded Nextremity Solutions, Inc. with seven additional patents. The patents are a mix of design and utility patents related to medical devices specific to the treatment of foot and ankle deformities.

Director of Product Development, Ryan Schlotterback stated, “We are pleased with the Nextremity Intellectual Property that was issued recently and feel that it is indicative of the hard work and talent of our surgeon partners and product development staff.  We are proud of our unique product portfolio and are committed to developing innovative solutions that continue to advance the standard of care in the Foot and Ankle market.”

Some of the patents relate specifically to current implants that Nextremity Solutions markets, including the Nextra® Hammertoe Correction System, as well as the MSPTM Metatarsal Shortening System. Additional products in the Company’s product pipeline are also utilizing the technology developed in the issued patents.

“As surgeons, we start with a concept. When these visions become products and procedures that allow surgeons to offer their patients a unique and better solution, we as doctors have achieved something special,” said Nextremity Solutions founder Lon S. Weiner, MD.

Co-founder Stuart D. Katchis, MD noted, “All of our work at Nextremity Solutions has been focused on designing unique products that make complex foot and ankle surgical procedures more consistently successful.  The issuance of these patents and the success we have seen clinically, confirm the value of our products to surgeons and patients alike.”

“The issuance of these patents by the USPTO is definitely exciting for us as a company. It truly speaks to the fact that we, as a pure-play foot and ankle company, are committed to working closely with our foot and ankle surgeon partners to develop innovative solutions in the foot and ankle market,” commented Rod K. Mayer, President of Nextremity Solutions.

 

About Nextremity Solutions, Inc.

Nextremity Solutions, Inc. is a privately held medical device company offering innovative solutions and approaches to foot and ankle surgical intervention. The Company’s procedure-ready, sterile implant systems for the correction of foot and ankle pathologies include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

 

For further information, visit www.nextremitysolutions.com or call Dave Temple, Director of Marketing & Corporate Communications at 574-635-3022.

Nextremity Solutions, Inc. Receives FDA 510(k) Approval for the Arcus™ Staple System

Warsaw, Indiana, September 8, 2015 — Nextremity Solutions, Inc., a pure-play foot and ankle company, recently received 510(k) approval by the Food & Drug Administration to market its upcoming ArcusTM Staple System.

“We are excited about the recent 510(k) approval of Nextremity’s new ArcusTM Staple System.  The unique design of our new staple generates excellent compression and is indicated for use throughout the foot and ankle.  Our testing has shown that the ArcusTM Staple performs better at maintaining compression over time when compared to the competition.  We look forward to the first implantations later this year,” said Director of Product Development, Ryan Schlotterback.

Rod K. Mayer, President of Nextremity Solutions said, “I’m extremely proud of the hard work our product development team has put into this product line. By working closely with our surgeon partners, we have developed a truly unique staple that will provide for more stable fixations in foot and ankle deformity correction, as well as trauma applications and other uses. We look forward to getting this product into the marketplace.”

The Nextremity Solutions Arcus™ Staple System is indicated for fixation of bone fractures, bone reconstruction, ligament, soft tissue and tendon. This includes, fixation of bone fragments or small bones fractures, as well as fracture management in the foot and hand. An application for a CE mark is pending.

 

About Nextremity Solutions, Inc.

Nextremity Solutions, Inc. is a privately held medical device company offering innovative solutions and approaches to foot and ankle surgical intervention. The Company’s procedure-ready, sterile implant systems for the correction of foot and ankle pathologies include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

For further information, visit www.nextremitysolutions.com or call Dave Temple, Director of Marketing & Corporate Communications at 574-635-3023.